Stocks making the biggest moves midday: Nvidia, Logitech, Nikola, Uber, Cleveland-Cliffs and more

Stocks making the biggest moves midday: Nvidia, Logitech, Nikola, Uber, Cleveland-Cliffs and more


NVIDIA President and CEO Jen-Hsun Huang

Robert Galbraith | Reuters

Check out the companies making headlines in midday trading.

KB Home — Shares of the homebuilder ticked 5% lower in midday trading after missing on the top and bottom lines of its quarterly results. KB Home reported earnings of $1.47 per share on revenue of about $1.40 billion. Wall Street expected earnings of $1.56 per share on revenue of $1.50 billion, according to Refinitiv.

Nikola — Shares for the electric vehicle company jumped 3.6%. The company began production of the battery-electric version of its Tre semitruck in its Coolidge, Arizona, factory.

Nvidia, Intel — Shares for the two companies popped in midday trading after reports that Nvidia may consider sourcing computer chips from Intel, according to Bloomberg. Also, Intel CEO Pat Gelsinger has been pushing government officials in the U.S. to support legislation to assist semiconductor production. Nvidia’s stock price jumped 8.4%, and Intel jumped 5.4%.

GameStop — Shares of the video game retailer retreated 5% following a seven-day winning streak. The stock surged 14% on Wednesday after Chair Ryan Cohen bought 100,000 more shares and raised his stake to 11.9%.

Steelcase — Shares of the office furniture maker tumbled more than 7% in midday trading. The company reported an unexpected loss for its most recent quarter, even as revenue exceeded expectations. Steelcase cited supply chain issues and inflationary pressures.

Logitech — Shares of the computer peripherals manufacturer jumped 6.4% after Bank of America initiated coverage of the company with a buy rating. Though the stock is down about 13% this year, the analyst covering Logitech said it’s “too inexpensive to ignore.”

NetApp — The cloud company’s stock price dipped 2.2% in midday trading. Bank of America analysts on Thursday downgraded the firm to neutral from buy, saying NetApp has limited upside from here.

Uber — Shares of the ride-sharing company jumped close to 4% on news that it reached a deal to feature New York City taxis on its app. Through the deal, Uber will work with taxi-hailing apps Curb and Creative Mobile Technologies.

Cleveland-Cliffs — Shares for the firm soared nearly 10% in midday trading as global shortages in steel spurred interest in the manufacturer.

Liberty Global — Shares of the European telecommunications company rose 1.7% after Credit Suisse upgraded the stock to outperform from neutral. The firm said in a note that “momentum was turning” for Liberty.

— CNBC’s Margaret Fitzgerald, Yun Li, Tanaya Macheel, Jesse Pound and Samantha Subin contributed reporting.



Source

The  million Trump Card faces legal challenges, limited market
Business

The $5 million Trump Card faces legal challenges, limited market

U.S. President Donald Trump holds “The Trump Card” as he speaks with journalists onboard Air Force One en route to Miami, Florida, U.S., April 3, 2025. Kent Nishimura | Reuters A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to […]

Read More
Nike will report earnings after the bell. Here’s what Wall Street expects
Business

Nike will report earnings after the bell. Here’s what Wall Street expects

A shopper walks past a Nike store, as global markets brace for a hit to trade and growth caused by U.S. President Donald Trump’s decision to impose import tariffs on dozens of countries, in the King of Prussia Mall in King of Prussia, Pennsylvania, U.S., April 3, 2025.  Rachel Wisniewski | Reuters Nike is expected […]

Read More
RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants
Business

RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants

Nikos Pekiaridis | Nurphoto | Getty Images Robert F. Kennedy Jr.’s revamped government panel of outside vaccine advisors on Thursday recommended the use of Merck‘s shot to protect infants from respiratory syncytial virus, a temporary reprieve for public health officials and companies concerned about the Health and Human Services secretary’s immunization policy. The group, called […]

Read More